Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Vranckx

Showing results (241-250 of 305) with videos related to

Pageof 31
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 20, 2019
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trialPatrick W Serruys, Mariusz Tomaniak, Ply Chichareon, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 16, 2020
Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trialHironori Hara, Norihiro Kogame, Kuniaki Takahashi, et al.
European Heart Journal|March 23, 2017
Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevationPascal Vranckx, Enrico Frigoli, Martina Rothenbühler, et al.
The American Journal of Cardiology|October 16, 2020
Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)Hideyuki Kawashima, Mariusz Tomaniak, Masafumi Ono, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 2, 2022
Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trialMasafumi Ono, Yoshinobu Onuma, Hideyuki Kawashima, et al.
European Heart Journal|May 17, 2022
Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysisMarco Valgimigli, Pieter C Smits, Enrico Frigoli, et al.
European Heart Journal. Acute Cardiovascular Care|September 23, 2023
2023 ESC Guidelines for the management of acute coronary syndromesRobert A Byrne, Xavier Rossello, J J Coughlan, et al.
Journal of the American College of Cardiology|October 6, 2012
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus documentA Pieter Kappetein, Stuart J Head, Philippe Généreux, et al.
Giornale Italiano Di Cardiologia (2006)|January 31, 2024
[2023 ESC Guidelines for the management of acute coronary syndromes]Robert A Byrne, Xavier Rossello, J J Coughlan, et al.
Nature Reviews. Cardiology|June 13, 2022
P2Y<sub>12</sub> inhibitor monotherapy in patients undergoing percutaneous coronary interventionDavide Capodanno, Usman Baber, Deepak L Bhatt, et al.
Pageof 31

Showing results (241-250 of 305) with videos related to

Sort By:
Pageof 31
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 20, 2019
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trialPatrick W Serruys, Mariusz Tomaniak, Ply Chichareon, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 16, 2020
Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trialHironori Hara, Norihiro Kogame, Kuniaki Takahashi, et al.
European Heart Journal|March 23, 2017
Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevationPascal Vranckx, Enrico Frigoli, Martina Rothenbühler, et al.
The American Journal of Cardiology|October 16, 2020
Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)Hideyuki Kawashima, Mariusz Tomaniak, Masafumi Ono, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 2, 2022
Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trialMasafumi Ono, Yoshinobu Onuma, Hideyuki Kawashima, et al.
European Heart Journal|May 17, 2022
Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysisMarco Valgimigli, Pieter C Smits, Enrico Frigoli, et al.
European Heart Journal. Acute Cardiovascular Care|September 23, 2023
2023 ESC Guidelines for the management of acute coronary syndromesRobert A Byrne, Xavier Rossello, J J Coughlan, et al.
Journal of the American College of Cardiology|October 6, 2012
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus documentA Pieter Kappetein, Stuart J Head, Philippe Généreux, et al.
Giornale Italiano Di Cardiologia (2006)|January 31, 2024
[2023 ESC Guidelines for the management of acute coronary syndromes]Robert A Byrne, Xavier Rossello, J J Coughlan, et al.
Nature Reviews. Cardiology|June 13, 2022
P2Y<sub>12</sub> inhibitor monotherapy in patients undergoing percutaneous coronary interventionDavide Capodanno, Usman Baber, Deepak L Bhatt, et al.
Pageof 31